Elevance Health, Inc. (ELV) stock
ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 21, 2026Score 16/3016% below fair value
$394.48+4.32 (+1.11%)
Close on Nov 20, 2026Market cap $85.23BP/E 16.8Yield –
Elevance Health gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Elevance Health's gross profit for the twelve months ending Sep 30, 2026 was $179.71B, up 3.8% year over year. For fiscal 2025 it was $177.95B, up 13.2% from the year before. Over ten years it grew 11.4% a year on average. The highest annual figure on record is $177.95B in fiscal 2025.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $177.95B | +13.2% |
| FY2024 | Dec 31, 2024 | $157.26B | +2.1% |
| FY2023 | Dec 31, 2023 | $154.05B | +7.3% |
| FY2022 | Dec 31, 2022 | $143.56B | +12.4% |
| FY2021 | Dec 31, 2021 | $127.74B | +13.1% |
| FY2020 | Dec 31, 2020 | $112.91B | +10.5% |
| FY2019 | Dec 31, 2019 | $102.22B | +11.0% |
| FY2018 | Dec 31, 2018 | $92.11B | +2.3% |
| FY2017 | Dec 31, 2017 | $90.04B | +46.7% |
| FY2012 | Dec 31, 2012 | $61.36B | +1.1% |
| FY2011 | Dec 31, 2011 | $60.71B | +3.4% |
| FY2010 | Dec 31, 2010 | $58.70B | -9.0% |
| FY2009 | Dec 31, 2009 | $64.52B | +6.1% |
| FY2008 | Dec 31, 2008 | $60.78B | +0.1% |
| FY2007 | Dec 31, 2007 | $60.74B | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $45.79B | +1.0% |
| Q2 FY2026 | Jun 30, 2026 | $44.98B | +1.1% |
| Q1 FY2026 | Mar 31, 2026 | $44.72B | +1.8% |
| Q4 FY2025 | Dec 31, 2025 | $44.23B | +12.2% |
| Q3 FY2025 | Sep 30, 2025 | $45.33B | +13.3% |
| Q2 FY2025 | Jun 30, 2025 | $44.48B | +13.9% |
| Q1 FY2025 | Mar 31, 2025 | $43.91B | +13.3% |
| Q4 FY2024 | Dec 31, 2024 | $39.43B | +4.3% |
| Q3 FY2024 | Sep 30, 2024 | $40.01B | +4.7% |
| Q2 FY2024 | Jun 30, 2024 | $39.07B | -0.7% |
| Q1 FY2024 | Mar 31, 2024 | $38.75B | +0.2% |
| Q4 FY2023 | Dec 31, 2023 | $37.81B | +4.2% |
| Q3 FY2023 | Sep 30, 2023 | $38.20B | +4.7% |
| Q2 FY2023 | Jun 30, 2023 | $39.35B | +10.6% |
| Q1 FY2023 | Mar 31, 2023 | $38.69B | +9.9% |
| Q4 FY2022 | Dec 31, 2022 | $36.28B | +8.3% |
| Q3 FY2022 | Sep 30, 2022 | $36.50B | +10.9% |
| Q2 FY2022 | Jun 30, 2022 | $35.56B | +13.8% |
| Q1 FY2022 | Mar 31, 2022 | $35.21B | +17.1% |
| Q4 FY2021 | Dec 31, 2021 | $33.51B | +14.4% |
| Q3 FY2021 | Sep 30, 2021 | $32.92B | +13.8% |
| Q2 FY2021 | Jun 30, 2021 | $31.24B | +15.5% |
| Q1 FY2021 | Mar 31, 2021 | $30.07B | +8.8% |
| Q4 FY2020 | Dec 31, 2020 | $29.30B | +11.6% |
| Q3 FY2020 | Sep 30, 2020 | $28.94B | +11.6% |
| Q2 FY2020 | Jun 30, 2020 | $27.04B | +6.6% |
| Q1 FY2020 | Mar 31, 2020 | $27.64B | +12.0% |
| Q4 FY2019 | Dec 31, 2019 | $26.26B | +12.3% |
| Q3 FY2019 | Sep 30, 2019 | $25.93B | +11.5% |
| Q2 FY2019 | Jun 30, 2019 | $25.37B | +10.6% |
| Q1 FY2019 | Mar 31, 2019 | $24.67B | – |
| Q4 FY2018 | Dec 31, 2018 | $23.37B | – |
| Q3 FY2018 | Sep 30, 2018 | $23.25B | – |
| Q2 FY2018 | Jun 30, 2018 | $22.94B | – |
See a number that looks wrong?